DRKS00030583招募中不适用
se of Bezlotoxumab for the Prevention of Clostridium difficile infections within the German health care system - an observational post-authorization study - BODEGA
niversitätsklinikum Frankfurt,0 个研究点目标入组 100 人开始时间: 2022年10月31日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Written informed consent
- •- Treatment of a C. diff. infection with bezlotoxumab or intended treatment with bezlotoxumab for the prevention of C. diff. infection
- •- Minimum age 18 years
排除标准
- •Patients which in the opinion of the investigator may interfere with the conduct of the study, such as incapacity to well understand, not willing to collaborate, or cannot easily be contacted after discharge
研究者
相似试验
终止
4 期
Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).Inflammatory Bowel DiseasesUlcerative ColitisC. Diff. InfectionsCrohn DiseaseNCT04626947David Binion, MD19
已完成
不适用
Prevention of infection in Liver Failure Patients.CTRI/2019/10/021548A143
终止
4 期
Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.Clostridia Difficile ColitisSepsis ClostridiumNCT03756454Ohio State University5
进行中（未招募）
3 期
A trial of using antibiotics to prevent infection in patients with advanced liver diseaseISRCTN33225996niversity College London442
已完成
不适用
Antimicrobial prophylaxis with tazobactam/piperacilin for prevention of postoperative infections after radical cystectomyRadical cystectomyJPRN-UMIN000005781Kobe University Graduate School of Medicine100